Ascentage pharma to report 2025 six month interim results and provide corporate update on august 20, 2025

Rockville, md. and suzhou, china, aug. 07, 2025 (globe newswire) -- ascentage pharma group international (nasdaq: aapg; hkex: 6855) (“ascentage pharma” or the “company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced today that it will release its six months 2025 unaudited interim results and provide business updates at 7:00 pm eastern daylight time (edt) on august 20, 2025 / 7:00 am hong kong time (hkt) on august 21, 2025.
AAPG Ratings Summary
AAPG Quant Ranking